abc-logo
  • Latest Articles
  • Diseases
    • Autoimmune Diseases
      • Arthritis
      • Crohn's Disease
      • Juvenile Arthritis
      • Lupus
      • Rheumatoid Arthritis
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Cancer
      • Myeloma
      • Leukemia
      • Lymphoma
      • Breast Cancer
      • Cervical Cancer
      • Brain Cancer
      • Colon Cancer
      • Kidney Cancer
      • Stomach Cancer
      • Lung Cancer
      • Skin Cancer
    • Heart Diseases
      • Heart Transplant
      • Heart Disease
      • High Cholesterol
      • Obesity
    • Infectious Diseases
      • Coronavirus
      • HIV/AIDS
      • Hepatitis C
      • HPV
    • Mental Health
      • Depression
      • Schizophrenia
      • Bipolar Disorder
    • Neurological Diseases
      • ALS
      • Alzheimer's
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Parkinson's
    • Treatment Approaches
      • Genomics
      • Vaccines
      • Immunologic
      • Treatments
  • About Us
    • Our Commitment
      • Development Pipeline
      • Innovation Fragility
      • Innovation Offsets
      • Accessibility & Affordability
      • R&D Commitment
    • Faces of Innovation
      • Champions / Advocates
      • Patient Profiles
      • Researcher Profiles
    • Member Companies
      • Who We Are
    • Campaigns
      • Breakthrough
      • Together
      • Do Not Go Gentle
      • New World
      • Cells
      • New Era of Medicine
    • Collaboration & Events
      • Events
  • SEARCH
  •  STAY AHEAD
  • Take Action
Hero Image Pattern 4
  1. Home
  2. Diseases
  3. A New Way to Fight Cancer

A New Way to Fight Cancer

Immunotherapy
Cells
Skin Cancer
Development Pipeline

It used to be science fiction. Harnessing your body’s own immune system to fight cancer. But what was once the fruit of a wild imagination is today a reality.

 

Rather than killing cancer cells directly with traditional approaches like radiation or chemotherapy, immunotherapy harnesses the immune system’s power to eliminate the cancer or slow its growth and ability to spread. Research shows immunotherapy is improving outcomes and survival rates for some patients, including kidney and lung cancer. In fact, research from the American Association for Cancer Research shows that for advanced-melanoma patients, survival rates are improving thanks in part to these new treatment options.

 

Biopharmaceutical researchers are urgently working to gain new insights into the complex interactions between patients’ immune systems and the cancer cells growing in their bodies with the goal of markedly improving outcomes in more tumor types.

It used to be science fiction. Harnessing your body’s own immune system to fight cancer.

With 836 medicines and vaccines in development for cancer, 80 percent of which have the potential to be first-in-class treatments, millions of Americans living with cancer have hope for a brighter future.

 

Welcome to the new era of medicine.

 

For all of us.

GET THE LATEST IN INNOVATION NEWS

Subscribe to receive the latest in medical innovation, treatment insights, and inspirational stories.

SUBSCRIBE NOW

RELATED TOPICS

Immunotherapy
Cells
Skin Cancer
Development Pipeline

Share:

  • #GoBoldly

Explore the innovative research and technological breakthroughs of America's biopharmaceutical industry, and get to know the people behind the fight to prevent, treat and cure disease.

abc-logo
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.

  • DISEASES
  • Cancer
  • Heart Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Mental Health
  • Neurological Diseases
  • Treatment Approaches

  • Take Action

  • About Us
  • Collaboration & Events
  • Our Commitment
  • Member Companies
  • Campaigns
  • Faces of Innovation
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.